SPHK2 and plasma cell myeloma: This study demonstrated an important role for SphK2 in myeloma pathogenesis since its knockdown inhibited myeloma cell proliferation and induced caspase-3 mediated apoptosis by upregulating Noxa expression and promoting Mcl-1 and c-Myc proteasomal degradation regardless if stromal cells were present.